secret_name,covid19_date_reporting,covid19_has_symptoms,covid19_sympt_fever,covid19_sympt_dry_cough,covid19_sympt_fatigue,covid19_sympt_pain,covid19_sympt_sore_throat,covid19_sympt_shortness_breath,covid19_sympt_nasal_congestion,covid19_sympt_chills,covid19_sympt_loss_smell_taste,covid19_sympt_pneumonia,covid19_suspected_case,covid19_self_isolation,covid19_self_isolation_by_self_patient,covid19_self_isolation_date,covid19_self_isolation_duration,covid19_confirmed_case,covid19_date_lab_test,covid19_country,covid19_date_suspected_onset,covid19_admission_hospital,covid19_admission_hospital_date,covid19_admission_hospital_release,covid19_icu_stay,covid19_still_icu_stay,covid19_icu_current_duration,covid19_icu_total_duration,covid19_ventilation,covid19_ventilation_non_invasive,covid19_ventilation_invasive,covid19_ecmo,covid19_outcome_recovered,covid19_outcome_death,covid19_outcome_death_date,age_years,sex,pregnancy,current_smoker,former_smoker,height,weight,is_healthcare_profession,ms_type,ms_onset_date,ms_diagnosis_date,edss_date_diagnosis,edss_value,last_white_blood_cell,last_white_blood_cell_unit,last_lympho_cell,last_lympho_cell_unit,last_b_cell,last_b_cell_unit,current_dmt,type_dmt,type_dmt_other,dmt_start_date,dmt_end_date,dmt_stop_date,dmt_stop_reason,dmt_glucocorticoid,dmt_glucocorticoid_start_date,dmt_glucocorticoid_stop_date,dmt_glucocorticoid_dosage_value,dmt_glucocorticoid_dosage_unit,has_comorbidities,com_cardiovascular_disease,com_hypertension,com_diabetes,com_chronic_liver_disease,com_chronic_kidney_disease,com_neurological_neuromuscular,com_lung_disease,com_immunodeficiency,com_malignancy,com_other
PREFIX_FMBGG/1,15/05/1983,yes,no,no,no,yes,no,yes,yes,yes,no,yes,no,no,yes,15/05/1983,8.96,yes,15/05/1983,example content,19/02/2013,no,16/10/2019,19/02/2013,no,yes,15.23,1.236,yes,no,no,yes,not_applicable,yes,12/05/2017,200,non-binary,no,no,no,15.23,1.236,yes,CIS,15/05/1983,15/05/1983,15/05/1983,8.96,170.25,lorem ipsum,8.96,lorem ipsum,170.25,example text,never_treated,interferons,lorem ipsum,16/10/2019,15/05/1983,19/02/2013,onset_covid,yes,12/05/2017,19/02/2013,1.236,example content,no,yes,yes,no,yes,no,no,no,no,no,lorem ipsum
PREFIX_KWKYT/1,16/10/2019,no,yes,yes,no,yes,no,yes,no,yes,no,yes,yes,no,yes,16/10/2019,15.23,no,12/05/2017,example content,16/10/2019,no,12/05/2017,12/05/2017,no,no,170.25,15.23,yes,yes,yes,no,yes,no,15/05/1983,160.23,female,no,yes,no,8.96,7.78,yes,CIS,12/05/2017,19/02/2013,12/05/2017,1.236,160.23,example content,170.25,example content,170.25,example text,yes,interferons,example text,16/10/2019,15/05/1983,19/02/2013,onset_covid,no,16/10/2019,12/05/2017,15.23,lorem ipsum,yes,no,no,no,no,no,yes,yes,no,yes,example text
PREFIX_BOUNF/1,12/05/2017,no,no,yes,yes,yes,no,no,yes,yes,yes,no,no,yes,yes,19/02/2013,7.78,no,15/05/1983,example text,19/02/2013,no,16/10/2019,16/10/2019,no,no,15.23,8.96,yes,yes,yes,yes,no,no,15/05/1983,170.25,male,no,yes,yes,15.23,170.25,yes,CIS,15/05/1983,19/02/2013,19/02/2013,1.236,7.78,lorem ipsum,170.25,example content,160.23,example text,yes,cladribine,lorem ipsum,12/05/2017,16/10/2019,19/02/2013,adverse_event,yes,12/05/2017,19/02/2013,7.78,example text,no,yes,yes,yes,yes,yes,yes,yes,no,yes,example content
PREFIX_FUJYX/1,15/05/1983,no,no,yes,no,yes,no,yes,yes,yes,yes,yes,no,no,yes,19/02/2013,7.78,no,15/05/1983,example content,19/02/2013,no,12/05/2017,15/05/1983,yes,yes,170.25,1.236,no,yes,yes,yes,no,yes,12/05/2017,7.78,male,no,yes,no,15.23,7.78,yes,PPMS,19/02/2013,15/05/1983,19/02/2013,1.236,170.25,example text,7.78,example content,7.78,example content,no,teriflunomide,example content,16/10/2019,15/05/1983,19/02/2013,patient_decision,yes,12/05/2017,16/10/2019,15.23,example content,no,yes,yes,no,yes,no,yes,yes,yes,no,example text
PREFIX_IUGSA/1,16/10/2019,no,yes,yes,yes,no,yes,no,no,yes,no,yes,no,no,yes,16/10/2019,8.96,yes,19/02/2013,example content,16/10/2019,no,19/02/2013,16/10/2019,no,yes,1.236,1.236,no,no,yes,yes,not_applicable,yes,15/05/1983,8.96,male,yes,yes,yes,1.236,15.23,yes,not_sure,12/05/2017,15/05/1983,19/02/2013,7.78,160.23,example text,8.96,example content,170.25,example text,yes,teriflunomide,example content,12/05/2017,15/05/1983,12/05/2017,patient_decision,no,16/10/2019,12/05/2017,8.96,example content,yes,no,no,yes,no,yes,no,no,yes,yes,example text
PREFIX_ULRAP/1,15/05/1983,yes,no,yes,yes,no,yes,no,yes,yes,yes,yes,no,yes,no,19/02/2013,8.96,yes,12/05/2017,example text,15/05/1983,yes,16/10/2019,16/10/2019,yes,no,1.236,8.96,yes,yes,yes,yes,no,no,19/02/2013,1.236,female,yes,yes,yes,160.23,15.23,yes,SPMS,16/10/2019,16/10/2019,16/10/2019,8.96,1.236,lorem ipsum,160.23,example text,7.78,example content,never_treated,cladribine,example content,12/05/2017,19/02/2013,19/02/2013,pregnancy,yes,15/05/1983,16/10/2019,15.23,example text,no,no,no,yes,yes,yes,no,yes,no,no,example text
PREFIX_SHCAO/1,12/05/2017,no,yes,no,yes,no,yes,no,yes,no,no,no,yes,yes,no,16/10/2019,15.23,yes,16/10/2019,example content,16/10/2019,yes,19/02/2013,15/05/1983,yes,yes,170.25,1.236,yes,yes,no,yes,yes,yes,16/10/2019,8.96,male,no,no,no,1.236,1.236,no,CIS,12/05/2017,16/10/2019,16/10/2019,1.236,7.78,lorem ipsum,170.25,lorem ipsum,8.96,example text,never_treated,fingolimod,lorem ipsum,16/10/2019,16/10/2019,15/05/1983,patient_decision,yes,16/10/2019,12/05/2017,160.23,lorem ipsum,no,yes,yes,yes,yes,yes,yes,yes,yes,yes,example content
PREFIX_UNGSF/1,19/02/2013,no,yes,yes,no,no,no,yes,yes,no,no,yes,yes,no,no,15/05/1983,7.78,no,12/05/2017,example text,15/05/1983,no,12/05/2017,16/10/2019,no,no,15.23,160.23,yes,yes,yes,yes,no,no,19/02/2013,7.78,male,yes,yes,no,170.25,15.23,no,not_sure,19/02/2013,12/05/2017,12/05/2017,8.96,7.78,lorem ipsum,1.236,example text,170.25,example content,never_treated,cladribine,example text,12/05/2017,12/05/2017,16/10/2019,pregnancy,no,16/10/2019,12/05/2017,160.23,lorem ipsum,no,yes,no,no,yes,yes,yes,yes,yes,yes,lorem ipsum
PREFIX_XOJVL/1,12/05/2017,yes,no,yes,no,no,no,no,yes,no,yes,yes,yes,yes,no,15/05/1983,7.78,no,15/05/1983,example text,19/02/2013,no,15/05/1983,19/02/2013,no,no,170.25,160.23,no,yes,no,yes,not_applicable,no,16/10/2019,15.23,male,yes,no,yes,15.23,160.23,yes,SPMS,15/05/1983,16/10/2019,15/05/1983,160.23,160.23,example text,170.25,example text,170.25,example content,no,siponimod,lorem ipsum,15/05/1983,19/02/2013,15/05/1983,adverse_event,no,19/02/2013,19/02/2013,160.23,example text,yes,yes,yes,no,no,yes,no,no,no,yes,lorem ipsum
PREFIX_DXZRO/1,16/10/2019,no,yes,yes,yes,no,yes,no,no,yes,no,no,yes,no,no,19/02/2013,1.236,yes,12/05/2017,lorem ipsum,12/05/2017,yes,16/10/2019,12/05/2017,no,no,7.78,160.23,yes,yes,yes,yes,not_applicable,yes,19/02/2013,160.23,male,no,no,no,160.23,170.25,no,PPMS,12/05/2017,12/05/2017,19/02/2013,1.236,1.236,example text,1.236,example text,160.23,example text,never_treated,teriflunomide,lorem ipsum,16/10/2019,15/05/1983,16/10/2019,onset_covid,yes,12/05/2017,12/05/2017,7.78,example text,yes,yes,yes,yes,yes,no,yes,no,no,yes,lorem ipsum
PREFIX_DEXVM/1,12/05/2017,no,no,no,no,yes,no,yes,no,no,no,no,yes,yes,no,16/10/2019,8.96,no,12/05/2017,example content,16/10/2019,no,12/05/2017,12/05/2017,no,no,8.96,160.23,yes,no,yes,no,no,no,19/02/2013,8.96,male,yes,yes,no,8.96,1.236,yes,SPMS,16/10/2019,12/05/2017,16/10/2019,7.78,7.78,example content,170.25,example text,1.236,example content,never_treated,siponimod,example content,12/05/2017,15/05/1983,16/10/2019,adverse_event,no,15/05/1983,19/02/2013,160.23,example content,yes,no,yes,no,yes,yes,no,yes,yes,no,example text
PREFIX_FLOPC/1,15/05/1983,yes,yes,yes,no,yes,yes,yes,no,no,yes,no,yes,yes,no,16/10/2019,1.236,yes,12/05/2017,lorem ipsum,15/05/1983,yes,16/10/2019,19/02/2013,yes,no,170.25,1.236,no,yes,no,no,not_applicable,yes,16/10/2019,7.78,female,no,no,yes,8.96,160.23,yes,PPMS,19/02/2013,12/05/2017,12/05/2017,15.23,160.23,example text,170.25,example text,170.25,lorem ipsum,yes,rituximab,lorem ipsum,19/02/2013,16/10/2019,15/05/1983,patient_decision,no,12/05/2017,16/10/2019,15.23,example content,yes,no,yes,yes,yes,yes,no,no,yes,yes,example content
PREFIX_YEEZT/1,16/10/2019,yes,yes,yes,no,no,no,no,no,yes,yes,no,yes,yes,no,16/10/2019,170.25,yes,15/05/1983,example text,15/05/1983,yes,19/02/2013,12/05/2017,yes,no,1.236,1.236,no,yes,no,yes,not_applicable,no,15/05/1983,15.23,male,no,no,no,7.78,7.78,no,not_sure,16/10/2019,12/05/2017,15/05/1983,15.23,8.96,lorem ipsum,15.23,lorem ipsum,1.236,example content,never_treated,cladribine,example content,19/02/2013,15/05/1983,15/05/1983,onset_covid,no,15/05/1983,15/05/1983,15.23,lorem ipsum,no,no,no,no,no,yes,yes,yes,yes,no,lorem ipsum
PREFIX_CCLKS/1,19/02/2013,yes,no,no,no,no,yes,no,no,no,no,no,yes,yes,yes,16/10/2019,170.25,no,12/05/2017,lorem ipsum,12/05/2017,yes,12/05/2017,19/02/2013,no,no,15.23,170.25,no,no,no,no,no,yes,12/05/2017,1.236,female,no,yes,no,170.25,170.25,yes,SPMS,15/05/1983,12/05/2017,16/10/2019,160.23,8.96,lorem ipsum,160.23,lorem ipsum,8.96,example text,never_treated,natalizumab,example content,16/10/2019,19/02/2013,19/02/2013,lack_efficacy,no,16/10/2019,15/05/1983,1.236,example text,no,no,yes,no,yes,yes,yes,no,yes,yes,example content
PREFIX_MIDOH/1,15/05/1983,no,no,yes,no,no,yes,yes,yes,no,no,yes,yes,no,yes,15/05/1983,8.96,no,15/05/1983,lorem ipsum,19/02/2013,yes,19/02/2013,15/05/1983,yes,yes,170.25,8.96,no,no,no,no,yes,no,16/10/2019,8.96,non-binary,no,no,yes,15.23,170.25,yes,SPMS,16/10/2019,15/05/1983,19/02/2013,15.23,1.236,example text,8.96,example text,1.236,example content,yes,teriflunomide,example content,16/10/2019,16/10/2019,16/10/2019,pregnancy,yes,12/05/2017,16/10/2019,160.23,example text,no,no,no,no,no,yes,no,no,yes,no,example text
PREFIX_QMEUP/1,15/05/1983,yes,yes,yes,yes,no,no,no,no,no,no,no,yes,no,no,12/05/2017,170.25,no,15/05/1983,lorem ipsum,16/10/2019,yes,15/05/1983,19/02/2013,no,no,170.25,8.96,yes,no,no,no,no,no,12/05/2017,7.78,female,yes,yes,yes,8.96,7.78,no,SPMS,12/05/2017,12/05/2017,19/02/2013,1.236,160.23,example content,170.25,example text,170.25,example content,never_treated,teriflunomide,example text,19/02/2013,19/02/2013,15/05/1983,patient_decision,no,12/05/2017,15/05/1983,15.23,example text,yes,no,yes,yes,yes,no,no,yes,yes,yes,example text
PREFIX_LBSTW/1,19/02/2013,no,yes,yes,yes,no,no,yes,yes,yes,no,no,yes,no,no,16/10/2019,8.96,yes,16/10/2019,example content,12/05/2017,no,16/10/2019,12/05/2017,no,no,15.23,160.23,no,yes,no,no,yes,yes,12/05/2017,1.236,non-binary,yes,no,no,8.96,1.236,yes,SPMS,12/05/2017,19/02/2013,19/02/2013,160.23,8.96,example content,1.236,lorem ipsum,15.23,example text,never_treated,rituximab,lorem ipsum,16/10/2019,12/05/2017,15/05/1983,patient_decision,yes,15/05/1983,15/05/1983,15.23,example content,no,no,yes,no,no,yes,yes,no,yes,yes,example text
PREFIX_YEEBJ/1,16/10/2019,no,no,yes,no,no,yes,yes,yes,no,no,no,yes,no,no,12/05/2017,8.96,no,16/10/2019,example text,15/05/1983,yes,15/05/1983,19/02/2013,no,no,1.236,7.78,yes,yes,no,no,no,yes,16/10/2019,160.23,male,no,no,yes,8.96,160.23,no,not_sure,19/02/2013,16/10/2019,12/05/2017,7.78,8.96,example text,170.25,example text,15.23,example content,yes,cladribine,example text,19/02/2013,15/05/1983,19/02/2013,patient_decision,no,19/02/2013,15/05/1983,160.23,example content,no,no,no,no,no,no,yes,yes,no,yes,example text
PREFIX_PDRVK/1,12/05/2017,yes,no,yes,no,yes,yes,no,yes,yes,no,no,no,no,no,16/10/2019,170.25,yes,19/02/2013,example content,12/05/2017,yes,19/02/2013,16/10/2019,yes,no,8.96,7.78,no,yes,no,no,no,yes,15/05/1983,7.78,female,yes,yes,no,1.236,160.23,yes,RRMS,12/05/2017,15/05/1983,16/10/2019,160.23,1.236,example text,160.23,example content,1.236,example content,yes,rituximab,lorem ipsum,12/05/2017,16/10/2019,19/02/2013,adverse_event,no,15/05/1983,16/10/2019,8.96,lorem ipsum,no,yes,yes,yes,no,no,no,yes,no,no,example content
PREFIX_RPSFP/1,19/02/2013,yes,no,no,yes,no,no,yes,yes,yes,yes,no,yes,yes,yes,16/10/2019,7.78,yes,12/05/2017,example text,19/02/2013,yes,19/02/2013,12/05/2017,no,yes,7.78,7.78,no,yes,no,no,no,yes,15/05/1983,1.236,non-binary,yes,yes,yes,170.25,7.78,no,SPMS,16/10/2019,19/02/2013,19/02/2013,8.96,15.23,example text,170.25,example text,7.78,example text,never_treated,cladribine,example content,12/05/2017,16/10/2019,19/02/2013,lack_efficacy,yes,16/10/2019,12/05/2017,160.23,lorem ipsum,yes,yes,no,yes,no,no,yes,yes,no,yes,example text
PREFIX_ORQQH/1,16/10/2019,no,yes,no,yes,no,yes,no,yes,yes,yes,yes,yes,no,yes,12/05/2017,8.96,yes,12/05/2017,example content,12/05/2017,no,12/05/2017,16/10/2019,yes,no,8.96,8.96,yes,yes,yes,yes,yes,yes,12/05/2017,170.25,male,yes,no,yes,15.23,8.96,no,CIS,12/05/2017,19/02/2013,19/02/2013,7.78,8.96,lorem ipsum,160.23,example text,170.25,example text,no,natalizumab,lorem ipsum,15/05/1983,15/05/1983,12/05/2017,onset_covid,no,16/10/2019,15/05/1983,1.236,lorem ipsum,yes,no,yes,no,yes,no,no,yes,yes,yes,example content
PREFIX_CCZUJ/1,15/05/1983,no,yes,yes,yes,no,no,yes,no,no,no,yes,no,no,yes,15/05/1983,1.236,no,15/05/1983,lorem ipsum,16/10/2019,no,19/02/2013,12/05/2017,yes,no,1.236,1.236,no,yes,no,no,not_applicable,yes,12/05/2017,7.78,female,no,yes,no,8.96,7.78,yes,PPMS,16/10/2019,12/05/2017,15/05/1983,15.23,1.236,example text,15.23,example text,8.96,example content,no,interferons,example text,16/10/2019,16/10/2019,19/02/2013,pregnancy,no,16/10/2019,19/02/2013,170.25,example text,no,no,yes,no,no,yes,yes,no,yes,no,lorem ipsum
PREFIX_ODLNM/1,15/05/1983,yes,yes,no,no,no,no,no,yes,no,yes,yes,yes,yes,no,15/05/1983,7.78,yes,12/05/2017,lorem ipsum,12/05/2017,no,12/05/2017,19/02/2013,yes,yes,170.25,7.78,no,no,yes,no,no,yes,19/02/2013,1.236,male,yes,no,no,160.23,1.236,yes,RRMS,19/02/2013,15/05/1983,19/02/2013,8.96,7.78,example text,1.236,lorem ipsum,1.236,example text,never_treated,cladribine,lorem ipsum,15/05/1983,19/02/2013,19/02/2013,lack_efficacy,yes,16/10/2019,19/02/2013,160.23,example content,no,no,no,yes,yes,no,no,yes,yes,yes,lorem ipsum
PREFIX_VDSEC/1,19/02/2013,yes,yes,no,yes,no,yes,no,yes,yes,yes,no,yes,yes,no,12/05/2017,170.25,no,15/05/1983,example content,12/05/2017,yes,12/05/2017,16/10/2019,no,yes,160.23,1.236,no,no,yes,yes,no,no,12/05/2017,170.25,female,yes,yes,no,8.96,8.96,no,PPMS,12/05/2017,15/05/1983,12/05/2017,15.23,8.96,example text,170.25,example text,7.78,example content,yes,cladribine,example content,15/05/1983,19/02/2013,12/05/2017,lack_efficacy,yes,12/05/2017,12/05/2017,160.23,example text,yes,no,yes,no,no,yes,yes,yes,no,yes,example content
PREFIX_ZGZUJ/1,16/10/2019,no,yes,no,yes,no,no,yes,yes,yes,no,no,no,yes,no,15/05/1983,160.23,no,16/10/2019,example content,15/05/1983,yes,19/02/2013,12/05/2017,no,yes,1.236,1.236,no,no,no,no,yes,no,19/02/2013,170.25,non-binary,no,yes,yes,8.96,1.236,no,not_sure,19/02/2013,15/05/1983,15/05/1983,160.23,15.23,example text,160.23,example content,8.96,example text,yes,ocrelizumab,lorem ipsum,12/05/2017,15/05/1983,19/02/2013,patient_decision,yes,19/02/2013,16/10/2019,170.25,example content,yes,yes,no,no,no,yes,yes,yes,yes,no,lorem ipsum
PREFIX_WELVY/1,12/05/2017,yes,yes,yes,no,no,yes,yes,yes,yes,yes,no,yes,yes,yes,19/02/2013,1.236,no,12/05/2017,lorem ipsum,19/02/2013,yes,16/10/2019,12/05/2017,yes,yes,160.23,170.25,yes,yes,yes,no,yes,yes,12/05/2017,7.78,non-binary,no,no,yes,8.96,7.78,yes,PPMS,15/05/1983,19/02/2013,16/10/2019,8.96,8.96,example text,1.236,example text,1.236,example content,never_treated,fingolimod,example content,12/05/2017,16/10/2019,12/05/2017,adverse_event,no,19/02/2013,15/05/1983,160.23,example content,yes,yes,yes,yes,no,yes,yes,yes,yes,yes,example content
PREFIX_GGZRK/1,15/05/1983,yes,yes,no,yes,no,no,no,yes,no,no,yes,yes,no,no,19/02/2013,7.78,yes,16/10/2019,example content,19/02/2013,yes,19/02/2013,19/02/2013,no,yes,8.96,170.25,yes,yes,no,no,not_applicable,no,19/02/2013,1.236,male,no,yes,yes,15.23,160.23,no,CIS,15/05/1983,16/10/2019,16/10/2019,8.96,170.25,example content,8.96,example content,8.96,example content,never_treated,rituximab,lorem ipsum,16/10/2019,12/05/2017,16/10/2019,adverse_event,yes,16/10/2019,12/05/2017,8.96,example text,yes,yes,no,no,yes,no,yes,no,no,yes,lorem ipsum
PREFIX_GPHVI/1,16/10/2019,no,yes,no,no,yes,no,yes,no,no,yes,yes,yes,no,yes,19/02/2013,15.23,yes,15/05/1983,example content,16/10/2019,no,15/05/1983,16/10/2019,yes,no,8.96,1.236,yes,yes,yes,yes,no,no,12/05/2017,7.78,non-binary,no,no,yes,15.23,15.23,no,PPMS,16/10/2019,19/02/2013,16/10/2019,8.96,15.23,example text,160.23,example content,15.23,lorem ipsum,yes,ocrelizumab,lorem ipsum,16/10/2019,16/10/2019,19/02/2013,onset_covid,no,19/02/2013,19/02/2013,8.96,lorem ipsum,yes,yes,yes,yes,yes,no,no,yes,no,yes,lorem ipsum
PREFIX_NLWQC/1,12/05/2017,yes,yes,no,yes,yes,yes,yes,no,yes,no,yes,no,no,no,16/10/2019,7.78,yes,12/05/2017,example text,15/05/1983,yes,16/10/2019,19/02/2013,no,yes,1.236,170.25,yes,yes,yes,no,no,yes,19/02/2013,160.23,female,no,no,no,1.236,170.25,yes,PPMS,12/05/2017,19/02/2013,12/05/2017,170.25,8.96,example text,160.23,lorem ipsum,15.23,lorem ipsum,yes,cladribine,example content,15/05/1983,15/05/1983,15/05/1983,adverse_event,no,16/10/2019,12/05/2017,170.25,example content,yes,no,no,yes,no,no,no,yes,yes,yes,example text
PREFIX_CLWJS/1,19/02/2013,yes,yes,no,yes,yes,no,yes,yes,no,yes,no,yes,yes,no,12/05/2017,160.23,yes,19/02/2013,example content,16/10/2019,yes,12/05/2017,12/05/2017,no,no,160.23,160.23,yes,no,no,no,no,no,16/10/2019,7.78,non-binary,no,yes,no,8.96,15.23,no,SPMS,16/10/2019,19/02/2013,16/10/2019,160.23,15.23,example content,7.78,example text,160.23,lorem ipsum,yes,alemtuzumab,example text,16/10/2019,12/05/2017,19/02/2013,lack_efficacy,yes,12/05/2017,16/10/2019,8.96,example content,yes,no,yes,yes,no,no,no,no,yes,no,example content
PREFIX_BFNTK/1,15/05/1983,no,no,no,yes,no,yes,yes,yes,no,yes,yes,yes,yes,yes,15/05/1983,7.78,yes,15/05/1983,example content,15/05/1983,no,15/05/1983,16/10/2019,yes,yes,1.236,15.23,yes,yes,no,yes,no,no,12/05/2017,1.236,non-binary,no,no,no,170.25,15.23,yes,CIS,15/05/1983,12/05/2017,12/05/2017,7.78,7.78,example content,160.23,example text,160.23,example text,no,ocrelizumab,example content,15/05/1983,12/05/2017,19/02/2013,onset_covid,no,12/05/2017,15/05/1983,1.236,example text,yes,no,yes,no,no,yes,no,no,yes,yes,example content
PREFIX_PJLYD/1,15/05/1983,yes,no,no,yes,yes,yes,yes,yes,no,no,no,no,no,yes,19/02/2013,15.23,no,15/05/1983,example content,16/10/2019,yes,15/05/1983,16/10/2019,no,no,7.78,1.236,no,no,yes,no,no,yes,16/10/2019,8.96,non-binary,yes,no,no,170.25,8.96,no,CIS,12/05/2017,16/10/2019,19/02/2013,8.96,15.23,example content,7.78,lorem ipsum,170.25,lorem ipsum,yes,natalizumab,lorem ipsum,12/05/2017,19/02/2013,19/02/2013,pregnancy,no,12/05/2017,12/05/2017,8.96,example content,no,yes,yes,yes,yes,no,yes,no,yes,yes,example content
PREFIX_HGJLE/1,16/10/2019,no,yes,yes,yes,no,yes,no,no,yes,no,yes,yes,no,yes,19/02/2013,170.25,yes,19/02/2013,example text,12/05/2017,no,12/05/2017,19/02/2013,yes,yes,1.236,15.23,no,yes,no,yes,yes,yes,19/02/2013,170.25,male,no,yes,yes,170.25,15.23,no,PPMS,12/05/2017,19/02/2013,16/10/2019,8.96,15.23,example text,160.23,example text,15.23,example text,yes,siponimod,example content,19/02/2013,12/05/2017,16/10/2019,lack_efficacy,no,15/05/1983,16/10/2019,7.78,lorem ipsum,yes,yes,no,yes,no,yes,yes,no,no,no,example text
PREFIX_YTVSA/1,15/05/1983,no,yes,yes,yes,yes,no,no,no,no,yes,no,no,yes,yes,19/02/2013,7.78,no,16/10/2019,lorem ipsum,12/05/2017,yes,16/10/2019,16/10/2019,no,no,7.78,170.25,no,yes,yes,no,not_applicable,no,16/10/2019,160.23,female,no,no,no,15.23,170.25,yes,CIS,12/05/2017,12/05/2017,16/10/2019,8.96,7.78,example text,7.78,example text,7.78,example content,no,siponimod,example content,19/02/2013,12/05/2017,19/02/2013,adverse_event,yes,12/05/2017,19/02/2013,7.78,example content,yes,no,yes,no,no,no,yes,yes,yes,yes,lorem ipsum
PREFIX_BUFLP/1,19/02/2013,no,yes,no,yes,no,no,no,yes,yes,yes,no,no,yes,yes,12/05/2017,7.78,no,16/10/2019,example content,15/05/1983,yes,15/05/1983,15/05/1983,yes,yes,170.25,170.25,no,no,yes,no,not_applicable,no,15/05/1983,170.25,non-binary,no,yes,yes,1.236,15.23,yes,CIS,19/02/2013,19/02/2013,19/02/2013,170.25,160.23,example text,160.23,example text,7.78,example content,no,alemtuzumab,example text,19/02/2013,15/05/1983,16/10/2019,lack_efficacy,no,15/05/1983,15/05/1983,1.236,lorem ipsum,yes,yes,yes,no,yes,yes,no,no,yes,yes,example content
PREFIX_SMXYX/1,19/02/2013,yes,no,yes,yes,no,yes,yes,no,no,yes,no,yes,no,yes,15/05/1983,1.236,yes,19/02/2013,example content,12/05/2017,no,16/10/2019,16/10/2019,yes,yes,170.25,170.25,no,yes,no,yes,no,no,16/10/2019,1.236,male,no,yes,no,1.236,15.23,no,PPMS,19/02/2013,16/10/2019,16/10/2019,170.25,160.23,lorem ipsum,160.23,lorem ipsum,15.23,example content,yes,teriflunomide,example content,16/10/2019,19/02/2013,12/05/2017,adverse_event,no,19/02/2013,15/05/1983,7.78,example text,no,no,yes,no,no,yes,no,yes,yes,no,lorem ipsum
PREFIX_VYPFT/1,19/02/2013,yes,no,no,no,yes,no,no,yes,no,yes,yes,no,yes,no,16/10/2019,8.96,no,16/10/2019,lorem ipsum,15/05/1983,yes,15/05/1983,15/05/1983,no,yes,15.23,8.96,yes,yes,yes,yes,no,no,19/02/2013,170.25,female,yes,yes,no,170.25,1.236,no,not_sure,16/10/2019,19/02/2013,15/05/1983,8.96,7.78,lorem ipsum,1.236,example text,8.96,example text,never_treated,rituximab,example text,15/05/1983,15/05/1983,19/02/2013,onset_covid,no,16/10/2019,16/10/2019,170.25,example content,yes,no,yes,no,no,yes,no,yes,yes,yes,example text
PREFIX_NRDUJ/1,15/05/1983,no,yes,yes,no,yes,no,yes,no,yes,no,yes,yes,no,yes,19/02/2013,170.25,no,16/10/2019,lorem ipsum,15/05/1983,no,15/05/1983,12/05/2017,no,yes,15.23,1.236,no,yes,no,yes,no,yes,12/05/2017,8.96,female,no,no,yes,160.23,1.236,no,not_sure,15/05/1983,16/10/2019,12/05/2017,15.23,160.23,example content,8.96,example content,1.236,example content,never_treated,glatiramer,example content,19/02/2013,15/05/1983,16/10/2019,adverse_event,no,12/05/2017,15/05/1983,8.96,example text,yes,no,no,yes,yes,no,no,no,yes,no,lorem ipsum
PREFIX_VDFVT/1,16/10/2019,no,yes,no,no,no,no,no,no,yes,yes,no,yes,no,no,15/05/1983,170.25,yes,16/10/2019,example content,12/05/2017,no,19/02/2013,19/02/2013,no,no,160.23,15.23,no,no,no,yes,not_applicable,yes,15/05/1983,1.236,non-binary,yes,yes,yes,1.236,7.78,no,not_sure,12/05/2017,12/05/2017,19/02/2013,170.25,160.23,example text,170.25,example content,1.236,lorem ipsum,yes,interferons,lorem ipsum,16/10/2019,19/02/2013,16/10/2019,lack_efficacy,no,19/02/2013,19/02/2013,7.78,example content,no,yes,no,yes,yes,no,yes,no,yes,no,lorem ipsum
PREFIX_IQRAM/1,15/05/1983,no,yes,no,yes,no,yes,yes,no,yes,yes,no,yes,no,yes,16/10/2019,15.23,yes,16/10/2019,lorem ipsum,16/10/2019,yes,19/02/2013,15/05/1983,no,yes,170.25,160.23,no,yes,yes,yes,not_applicable,yes,15/05/1983,160.23,female,yes,yes,no,170.25,7.78,no,not_sure,15/05/1983,12/05/2017,16/10/2019,8.96,7.78,lorem ipsum,160.23,example content,1.236,lorem ipsum,no,rituximab,example content,15/05/1983,19/02/2013,19/02/2013,pregnancy,yes,12/05/2017,16/10/2019,7.78,lorem ipsum,no,no,yes,no,yes,yes,no,yes,yes,yes,example text
PREFIX_ZSDQV/1,15/05/1983,yes,yes,no,no,yes,yes,no,yes,yes,no,yes,no,no,no,15/05/1983,170.25,yes,15/05/1983,example content,16/10/2019,yes,12/05/2017,19/02/2013,yes,yes,8.96,1.236,yes,no,no,yes,yes,yes,12/05/2017,170.25,female,no,yes,no,170.25,1.236,no,RRMS,12/05/2017,15/05/1983,12/05/2017,15.23,8.96,lorem ipsum,1.236,example text,8.96,example content,never_treated,alemtuzumab,lorem ipsum,12/05/2017,19/02/2013,16/10/2019,patient_decision,no,12/05/2017,12/05/2017,8.96,example content,yes,no,yes,no,yes,no,no,no,yes,no,example text
PREFIX_MXLXA/1,16/10/2019,yes,no,no,yes,yes,yes,yes,no,yes,yes,yes,yes,no,yes,16/10/2019,15.23,yes,15/05/1983,example content,15/05/1983,yes,15/05/1983,19/02/2013,yes,no,15.23,160.23,yes,no,no,no,yes,yes,16/10/2019,8.96,male,no,yes,yes,15.23,160.23,yes,SPMS,12/05/2017,12/05/2017,12/05/2017,15.23,8.96,example text,7.78,example content,7.78,lorem ipsum,no,teriflunomide,example text,19/02/2013,15/05/1983,12/05/2017,patient_decision,yes,19/02/2013,12/05/2017,160.23,example content,no,yes,no,yes,no,no,yes,no,no,yes,lorem ipsum
PREFIX_KBXHP/1,16/10/2019,no,no,yes,yes,no,yes,yes,no,no,yes,no,no,yes,no,12/05/2017,7.78,no,15/05/1983,example content,12/05/2017,yes,19/02/2013,16/10/2019,no,no,8.96,8.96,no,yes,yes,yes,no,no,16/10/2019,1.236,male,yes,no,yes,7.78,15.23,no,CIS,16/10/2019,15/05/1983,12/05/2017,7.78,8.96,example text,7.78,example text,170.25,lorem ipsum,yes,fingolimod,lorem ipsum,12/05/2017,16/10/2019,19/02/2013,lack_efficacy,yes,15/05/1983,19/02/2013,170.25,example text,yes,no,yes,no,yes,no,yes,yes,no,no,lorem ipsum
PREFIX_PERLG/1,15/05/1983,no,no,no,no,no,yes,yes,yes,no,no,yes,yes,yes,no,12/05/2017,8.96,no,16/10/2019,example content,12/05/2017,no,16/10/2019,16/10/2019,yes,no,1.236,8.96,yes,no,no,yes,yes,no,15/05/1983,160.23,female,no,yes,yes,1.236,7.78,no,RRMS,16/10/2019,19/02/2013,15/05/1983,1.236,160.23,lorem ipsum,7.78,lorem ipsum,1.236,lorem ipsum,no,fingolimod,example content,19/02/2013,16/10/2019,19/02/2013,patient_decision,no,19/02/2013,16/10/2019,1.236,example text,yes,yes,yes,yes,no,yes,no,yes,no,yes,lorem ipsum
PREFIX_AVSQI/1,19/02/2013,no,no,no,no,yes,no,no,yes,no,no,no,yes,no,no,19/02/2013,170.25,no,16/10/2019,example content,16/10/2019,no,19/02/2013,19/02/2013,no,yes,1.236,15.23,no,yes,no,yes,not_applicable,no,19/02/2013,7.78,female,yes,yes,yes,1.236,8.96,no,RRMS,15/05/1983,16/10/2019,12/05/2017,170.25,7.78,example text,15.23,example text,7.78,example content,yes,interferons,lorem ipsum,19/02/2013,12/05/2017,16/10/2019,adverse_event,yes,19/02/2013,16/10/2019,7.78,example content,no,no,no,no,no,no,yes,yes,yes,no,example content
PREFIX_UQRID/1,19/02/2013,yes,no,no,yes,no,no,no,no,no,no,no,yes,yes,yes,16/10/2019,15.23,yes,15/05/1983,lorem ipsum,15/05/1983,yes,16/10/2019,19/02/2013,yes,no,170.25,8.96,yes,yes,yes,yes,not_applicable,no,15/05/1983,8.96,female,yes,yes,yes,15.23,7.78,no,SPMS,16/10/2019,12/05/2017,12/05/2017,7.78,1.236,example content,15.23,lorem ipsum,15.23,example content,no,cladribine,lorem ipsum,12/05/2017,16/10/2019,12/05/2017,lack_efficacy,no,19/02/2013,16/10/2019,160.23,lorem ipsum,yes,no,no,yes,no,no,no,yes,yes,no,example text
PREFIX_NRBSX/1,15/05/1983,yes,yes,no,no,yes,yes,yes,no,yes,no,no,yes,yes,yes,16/10/2019,160.23,no,15/05/1983,lorem ipsum,19/02/2013,yes,19/02/2013,15/05/1983,no,no,170.25,170.25,yes,no,yes,yes,no,yes,15/05/1983,8.96,male,yes,yes,no,15.23,1.236,yes,PPMS,12/05/2017,16/10/2019,15/05/1983,7.78,160.23,example text,15.23,example content,170.25,example content,never_treated,natalizumab,example text,16/10/2019,19/02/2013,16/10/2019,onset_covid,no,12/05/2017,15/05/1983,1.236,lorem ipsum,no,no,no,yes,yes,yes,no,no,no,no,lorem ipsum
PREFIX_NBDGA/1,16/10/2019,no,no,yes,no,no,yes,no,no,yes,no,yes,yes,yes,no,15/05/1983,15.23,yes,16/10/2019,example text,19/02/2013,yes,15/05/1983,12/05/2017,yes,yes,1.236,8.96,no,no,no,yes,yes,no,15/05/1983,8.96,female,yes,no,no,8.96,160.23,no,not_sure,16/10/2019,12/05/2017,12/05/2017,15.23,15.23,lorem ipsum,8.96,example text,1.236,example text,no,teriflunomide,lorem ipsum,16/10/2019,16/10/2019,19/02/2013,patient_decision,no,15/05/1983,16/10/2019,15.23,example text,no,yes,yes,yes,yes,no,yes,no,no,yes,lorem ipsum
PREFIX_TQKVI/1,16/10/2019,yes,yes,no,no,no,no,no,no,yes,no,no,no,no,no,15/05/1983,160.23,no,16/10/2019,example text,16/10/2019,no,15/05/1983,12/05/2017,yes,yes,170.25,15.23,yes,yes,yes,yes,yes,yes,15/05/1983,170.25,non-binary,no,yes,no,170.25,160.23,yes,RRMS,12/05/2017,16/10/2019,15/05/1983,15.23,1.236,example text,1.236,example text,8.96,example content,yes,siponimod,example text,16/10/2019,12/05/2017,12/05/2017,onset_covid,yes,12/05/2017,15/05/1983,1.236,example content,no,no,no,yes,yes,no,yes,yes,no,no,example content
PREFIX_CKJFQ/1,12/05/2017,no,no,no,yes,yes,no,yes,yes,no,yes,yes,yes,yes,yes,16/10/2019,1.236,no,12/05/2017,lorem ipsum,15/05/1983,no,19/02/2013,19/02/2013,yes,yes,15.23,1.236,no,yes,yes,no,yes,yes,12/05/2017,8.96,non-binary,yes,yes,no,15.23,160.23,no,PPMS,12/05/2017,16/10/2019,16/10/2019,160.23,8.96,example text,1.236,example content,170.25,example text,yes,glatiramer,example content,16/10/2019,15/05/1983,19/02/2013,lack_efficacy,no,15/05/1983,15/05/1983,1.236,example text,no,no,yes,yes,yes,no,no,yes,yes,yes,example content
